Vaduz Liechtenstein Charlevoix Sovereign Strategic Investment Fund
Additional shared vehicles: Sapphire Emerging Ventures VII (2025 Vintage) · SV Life Sciences Fund VI, L.P. (2025 Vintage)
$1.9B Total AUM · Institutional LP profile covering 22 historical fund disclosure records ($185.8M parsed USD across disclosed rows) across disclosed strategy exposure in Buyout, Venture Capital, Real Estate, Infrastructure, Multi-Strategy (investment geography mandates are evaluated separately from LP headquarters). 5 complete primary source trails are open below without registration.
Showing 5 open preview records out of 22 total tracked records (+17 gated pilot rows). Click Inspect Source on any row to view field-level substantiation, table headers/units, and archived page excerpts without login.
| Disclosed Fund / Vehicle | Strategy | Fund Vintage | Advised Vehicle GAV | Disclosed Performance | Primary Source Trail |
|---|---|---|---|---|---|
| Silver Lake Technology Investors VIIIAdviser 7.B Vehicle | Buyout | 2025 |
$10.2M
Adviser-managed fund GAV · As of March 2026
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · SEC Form ADV 7.B |
| Sapphire Emerging Ventures VIIAdviser 7.B Vehicle | Venture Capital | 2025 |
$5.2M
Adviser-managed fund GAV · As of March 2026
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · SEC Form ADV 7.B |
| SV Life Sciences Fund VI, L.P.Adviser 7.B Vehicle | Buyout | 2025 |
$5.2M
Adviser-managed fund GAV · As of March 2026
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · SEC Form ADV 7.B |
| SV7 Impact Medicine Fund, L.P.Adviser 7.B Vehicle | Buyout | 2025 |
$4.8M
Adviser-managed fund GAV · As of March 2026
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · SEC Form ADV 7.B |
| Lone Star Fund X (U.S), LPAdviser 7.B Vehicle | Buyout | 2025 |
$10.5M
Adviser-managed fund GAV · As of December 2025
|
Active 2025–2026 Drawdown · J-Curve / Initial Deployment Period | Inspect Source · SEC Form ADV 7.B |
Tracked separately from historical commitments: active RFPs/searches, board pacing plans, leadership/CIO updates, and retained gatekeeper consultants.
Lvw Advisors (Family Office / MFO, $1.9B AUM): Disclosed FY2025-2026 Private Markets Pacing & Allocation Update (PE Target 16.0% vs. 13.2% Actual; $53.1M Unallocated Target Bandwidth). SEC Form ADV (801-72830, CRD #159403) verified $1.90B discretionary AUM (Item 5.G.(12) External Private Manager Selection); active 2026 allocations across Fund I-IV Buyout, Growth/VC & Private Credit ($2M-$10M checks). Gatekeeper / Intake Conduit: Internal Investment Office.
Forward-looking board pacing or target-allocation policy update · Recorded 2025-05-08
Board-Approved Pacing Plans, Active RFPs & Target-vs-Actual Allocation Gap
Join waitlist for pacing dossier →
Retained Private Markets Advisors & Emerging-Manager Search Conduits
Join waitlist for consultant map →
CIO, Private Markets Officers & Official Pitch Intake Guidance
Join waitlist for team directory →
You are viewing 5 open public preview records (out of 22 total tracked records for Lvw Advisors) with zero-registration primary source trails. Join the early-access waitlist to request pilot access:
Enter your firm email to request pilot onboarding for Lvw Advisors and our interactive GP workspace.
Thank you for joining the Prilago early-access waitlist! We will reach out with pilot access details for your firm.
Lvw Advisors is categorized under Family Office / MFO (Regional Roadshow Hub: Pittsford, NY; Headquarters: Pittsford, NY). Across 22 historical disclosure records tracked on Prilago ($185.8M total parsed USD across disclosed rows), the median disclosed amount is $9.2M (range: $4.0M to $12.5M).
Lvw Advisors has disclosed records across Buyout, Venture Capital, Real Estate, Infrastructure, Multi-Strategy. Open preview records include Silver Lake Technology Investors VIII (2025 Vintage), Sapphire Emerging Ventures VII (2025 Vintage), SV Life Sciences Fund VI, L.P. (2025 Vintage), SV7 Impact Medicine Fund, L.P. (2025 Vintage).
Records for Lvw Advisors cite primary public disclosures (SEC Form ADV 7.B), and visitors can inspect 5 open source trails on this profile without registration. Each source trail displays field-level substantiation status, distinguishing exact commitment schedules from carrying-value or fee tables. Forward-looking active searches, RFPs, pacing plans, and governance updates are separated from historical disclosures.
General Partners can join the early-access waitlist on https://prilago.com/lp/lvw-advisors or test fund suitability in the interactive read-only demo at https://prilago.com/demo.
In Prilago's bilateral commitment graph, Lvw Advisors shares resolved underlying fund vehicles with 688 institutional LPs across 22 shared vehicles (shared fund exposure represents a potential introduction path and does not prove LPAC seat overlap or personal acquaintance). Top shared-fund peers include Vaduz Liechtenstein Charlevoix Sovereign Strategic Investment Fund (10 shared vehicles, e.g. Silver Lake Technology Investors VIII (2025 Vintage)), Blackstone Valley Gulf Breeze Holmberg Institutional Outsourced CIO & Wealth Advisory (10 shared vehicles, e.g. Sapphire Emerging Ventures VII (2025 Vintage)), Fairfield County Hopewell Pendleton Institutional Outsourced CIO & Wealth Advisory (10 shared vehicles, e.g. SV Life Sciences Fund VI, L.P. (2025 Vintage)).